Error: Could not add to watchlist. X
+ Watchlist

Nivalis Therapeutics Inc

NVLS:US
NASDAQ GM
8.16
USD
0.22
2.63%
As of 10:59 AM EDT 9/26/2016
Open
8.31
Day Range
8.16 - 8.59
Volume
30,429
Previous Close
8.38
52Wk Range
3.68 - 13.81
1 Yr Return
-40.35%
Open
8.31
Day Range
8.16 - 8.59
Volume
30,429
Previous Close
8.38
52Wk Range
3.68 - 13.81
1 Yr Return
-40.35%
YTD Return
5.43%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.87
Market Cap (m USD)
129.916
Shares Outstanding (m)
15.503
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Nivalis Therapeutics, Inc. operates as a clinical stage pharmaceutical company. The Company focuses on developing a portfolio of small molecule therapeutics for the treatment of major diseases such as cystic fibrosis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, and certain cardiovascular disorders.
Address
3122 Sterling Circle
Suite 200
Boulder, CO 80301
United States
Phone
1-720-945-7700
Show More